glp-1 drug news weight loss pill in development Risks of Ozempic, other GLP-1

Most of the research comes from animal studies, and even the researchers describe some of the effects as still unproven

Ongoing Monitoring and Safety Your bloodwork tracks growth hormone levels, IGF-1 production, fasting glucose, insulin sensitivity, and liver function to catch any adverse effects early

While Mounjaro is not a weight loss drug, the same study participants had an average weight loss of 17 to 25 pounds

A: While the nutrients immediately get to work in your bloodstream, it can take a week or two to start feeling a positive impact after an IV drip

Liz Bhatt, MS, MBA, President and COO

The shift toward chronic disease prevention and improved metabolic health is positioning GLP-1 receptor agonists as a cornerstone of modern obesity treatment strategies Restraint/Challenge Side Effects and High Treatment Costs Pose Adoption Barrier Concerns surrounding the side effects and high cost of GLP-1 receptor agonist therapies pose significant challenges to broader market adoption